Melissa Moore-Clingenpeel

Melissa Moore-Clingenpeel

Auto-generated profile, based on publicly available information

Melissa Moore-Clingenpeel

Biostatistics Core, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Epilepsy Research
Verified
Journal Article
Open access
JMJohn R. Mytinger
John R. Mytinger
JVJorge Vidaurre
Jorge Vidaurre
MMMelissa Moore-Clingenpeel
Melissa Moore-Clingenpeel
JSJoseph R. Stanek
Joseph R. Stanek
DADara V.F. Albert
Dara V.F. Albert
To develop an improved interictal electroencephalogram (EEG) grading scale for children with infantile spasms founded on elements with adequate inter-rater reliability (IRR) to justify its further study for clinical and research purposes. Three blinded reviewers assessed five-minute sleep epochs in 93 EEGs from 62 children (31 consecutive controls, 31 consecutive infantile spasms [pretreatment and posttreatment studies]) using a longitudinal bipolar montage. We determined the IRR of background amplitude, epileptiform discharges, >3 spike foci (including 50 %), grouped multifocal spikes, paroxysmal voltage attenuations, and symmetry of sleep spindles. Data were used to finalize the 2021 BASED (Burden of AmplitudeS and Epileptiform Discharges) score. All elements included in the 2021 BASED score had moderate to near perfect IRR. Among controls, >200 μv background waves occurred commonly in the bilateral posterior temporal (T3-T5, T4-T6) and midline (Fz-Cz, Cz-Pz) regions. Excluding midline and occipital channels (which have normal high amplitude background waves), we designated abnormal high amplitude background waves as >200 μv for most channels, but >300 μv for T3-T5 and T4-T6. The IRR was moderate to near perfect for 3 spike foci, >50 % >3 spike foci, paroxysmal voltage attenuations, grouped multifocal spikes (GMFS), and symmetric sleep spindles. Paroxysmal voltage attenuations, GMFS, and >50 % >3 spike foci all significantly distinguished pretreatment from posttreatment studies whereas symmetric sleep spindles did not (as planned, the latter was not included in the 2021 BASED score). When the 2021 BASED score was applied to the 22 children with infantile spasms achieving clinical remission with treatment, 19 met criteria for electroclinical remission and three did not. The 2021 BASED score includes elements with high levels of IRR and correlates well with the presence or absence of infantile spasms.

1 June 2016 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
MRMahmood Rafiq
Mahmood Rafiq
TWTariq M. Wani
Tariq M. Wani
MMMelissa Moore-Clingenpeel
Melissa Moore-Clingenpeel
JTJoseph D. Tobias
Joseph D. Tobias

9 April 2016 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
TWTariq M Wani
Tariq M Wani
MRMahmood Rafiq
Mahmood Rafiq
RTRayan Terkawi
Rayan Terkawi
MMMelissa Moore-Clingenpeel
Melissa Moore-Clingenpeel
MAMazen AlSohaibani
Mazen AlSohaibani
JTJoseph Tobias
Joseph Tobias

4 October 2020 in Lupus
Verified
Journal Article
Closed access
PDF file
OAOhoud AlAhmed
Ohoud AlAhmed
VSVidya Sivaraman
Vidya Sivaraman
MMMelissa Moore-Clingenpeel
Melissa Moore-Clingenpeel
SAStacy P Ardoin
Stacy P Ardoin
SBSharon Bout-Tabaku
Sharon Bout-Tabaku
FIfor the CARRA registry investigators
for the CARRA registry investigators
Objective: Polyautoimmunity (PA) with systemic lupus erythematosus (SLE) is reported as a poor prognostic factor, but little is known about its effect in childhood-onset SLE (cSLE). We describe PA in cSLE within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry and evaluate its association to lupus disease outcomes. Methods: CARRA Legacy Registry is the largest pediatric rheumatology registry that collected data at enrollment and every 6 months thereafter. We describe the co-occurrence of selected autoimmune disorders (autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus) in cSLE. To assess outcomes, we studied measures of lupus disease activity, complications, and patient’s quality of life (QoL). Comparisons by PA status were made using chi-square, Fisher’s exact test, two-sample t-tests, Wilcoxon rank sum tests, and mixed effects models as appropriate. Results: 1285 patients met the American College of Rheumatology criteria for SLE. Of those, 388 (30%) had data on comorbidity. The prevalence of PA was 8.8%. Patients with PA reported more hospitalizations and aggressive immunotherapy use. SLEDAI and PGA scores improved over time, but did not differ by PA status. No significant differences were found in QoL measures or their trajectory over time by PA status. Conclusion: In cSLE, PA is associated with more hospitalizations and aggressive immunotherapy use. Although lupus disease activity improved over time, patients' QoL neither improved over time nor differed by having other autoimmune disease. Prospective, case-control, long-term follow-up studies on cSLE are needed to validate our results. MeSH Key Indexing Terms: Pediatric systemic lupus erythematosus; Autoimmune diseases; Outcome assessment

1 October 2021 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
BSBrittany L. Shutes
Brittany L. Shutes
APAmbrish B. Patel
Ambrish B. Patel
MMMelissa D. Moore-Clingenpeel
Melissa D. Moore-Clingenpeel
AMAsuncion Mejias
Asuncion Mejias
TKTodd J. Karsies
Todd J. Karsies
Rationale: Although respiratory virus testing is frequently done for critically ill infants with bronchiolitis, the prognostic value of this testing is unknown for those requiring positive-pressure ventilation (PPV). Objectives: To determine the differences in PPV use according to viral detection and to explore the association between viral detection and duration of PPV in critically ill children with presumed respiratory infection. Methods: This is a retrospective cohort study in a quaternary pediatric intensive care unit from February 2014 until February 2017. We evaluated 984 children less than 1 year of age who received PPV for presumed respiratory infection without significant congenital heart disease, care limitations, baseline PPV usage, or tracheostomy. Respiratory viruses were identified using a PCR panel. Analyses of duration of PPV according to viral etiology were performed using univariate and multivariable logistic regression and truncated negative binomial regression with calculated mean marginal effects (MME). Results: Overall, 85 (9%) infants had no viruses identified, 629 (64%) had a single virus detected, most commonly respiratory syncytial virus (417, 42%) followed by rhinovirus/enterovirus (145, 15%), 230 (23%) had two viruses detected, and 40 (4%) had three viruses detected. Compared with those with one or no virus detected, infants with ⩾2 viruses received longer total PPV duration in adjusted analysis (relative risk [RR], 1.4; 95% confidence interval [CI], 1.2–1.6; P < 0.001; MME = 29 h). Detection of rhinovirus/enterovirus alone, compared with respiratory syncytial virus alone, was associated with significantly shorter duration of total PPV (RR, 0.7; 95% CI, 0.62–0.87; P = <0.001; MME = −23 h), noninvasive PPV (RR, 0.7; 95% CI, 0.60–0.85; P < 0.001; MME = −15 h), and invasive PPV (RR, 0.7; 95% CI, 0.54–0.83; P < 0.001; MME = −54 h) when adjusted for weight, prematurity, and administration of early antibiotic therapy. Conclusions: Identification of viral type and number in severe bronchiolitis is an important predictor of duration of PPV.

20 April 2017 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
JHJames L. Hungerford
James L. Hungerford
NONicole O’bRien
Nicole O’bRien
MMMelissa Moore-Clingenpeel
Melissa Moore-Clingenpeel
ESEric A. Sribnick
Eric A. Sribnick
CSCheryl Sargel
Cheryl Sargel
JTJoseph D. Tobias
Joseph D. Tobias
Objective: To determine whether remifentanil would provide adequate sedation while allowing frequent and reproducible neurologic assessments in children admitted to the pediatric intensive care unit (PICU) with traumatic brain injury (TBI) during mechanical ventilation. Design: Retrospective review. Setting: Tertiary care PICU. Patients: Thirty-eight patients over a 30-month period. Measurements and Main Results: Median age was 9 years (interquartile range [IQR] 2.25-12 years). The median Glasgow Coma Scale (GCS) was 9 (IQR: 8-10). All patients were tracheally intubated and receiving mechanical ventilation. A continuous infusion of remifentanil was started at 0.1 μg/kg/min, and bolus doses of 0.25 to 1 μg/kg were administered every 3 to 5 minutes as needed to reach the desired sedation level. Infusions were stopped at least hourly to perform neurologic examinations. The median remifentanil dose was 0.25 μg/kg/min with an IQR of 0.1 and 0.6 μg/kg/min. The maximum dose for any patient in the cohort was 2 μg/kg/min. Median duration of therapy with remifentanil was 20 hours (IQR: 8-44 hours). Adequate sedation was achieved with sedation scores (State Behavioral Scale) meeting target levels with a median value of 100% of the time (IQR: 79%-100%). Neurologic examinations were able to be performed within a median of 9 minutes (IQR: 5-14 minutes) of pausing the infusion. No serious safety events occurred. In 68% of the patients, neurologic examinations remained reassuring during remifentanil infusion, and patients were extubated. The remaining patients were transitioned to traditional sedative agents for long-term management of their traumatic injuries once the neurologic status was deemed stable. Conclusion: This data suggest that remifentanil is a suitable sedative agent for use in children with TBI. It provides a rapid onset of sedation with recovery that permits reliable and reproducible clinical examination.